GHRP-6
Growth Hormone Releasing Peptide-6, Growth hormone-releasing hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
Stimulation of Ca2+ entry in lactotrophs and somatotrophs from immature rat pituitary by N-terminal fragments of proopiomelanocortin.
Lorsignol. A A; Himpens. B B; Denef. C C
Key Findings
- POMC1‑76 and its shorter version POMC1‑26 trigger oscillating calcium increases in a small subset of immature pituitary cells.
- Roughly one‑third of the calcium‑responsive cells also respond to GHRP‑6, linking the response to somatotroph (growth‑hormone) cells.
- Calcium influx depends on extracellular calcium, is reduced by L‑type channel blocker nifedipine, and is partially mediated by protein kinase A.
Practical Outcomes
- The data support the idea that GHRP‑6 can activate growth‑hormone‑producing cells by promoting calcium entry, which helps explain its GH‑releasing effect. However, the study is in neonatal rat pituitary tissue, so it offers no direct dosing or safety guidance for human use. Biohackers can view this as mechanistic confirmation but should not change protocols based on it alone.
Summary
In young rat pituitary cells, tiny pieces of the hormone precursor POMC (including the part that looks like GHRP‑6) cause the cells to let calcium flow in, which is a key step for hormone release. About a third of the cells that reacted to these fragments also reacted to GHRP‑6 itself, suggesting they are the growth‑hormone‑making cells. The calcium entry needs outside calcium and is partly blocked by drugs that target L‑type calcium channels and the PKA signaling pathway.
Abstract
We have previously shown that 10-12 kDa N-terminal fragments of rat proopiomelanocortin (POMC) and human POMC1-76 stimulate mitosis and/or differentiation in lactotrophs of early postnatal rat pituitary. A truncated form, POMC1-26, mimics the differentiation-inducing but not the mitogenic action of the former peptides. To further characterize these two biological responses, the present study compared changes in the intracellular free calcium concentration ([Ca2+]i) in response to POMC1-76 and POMC1-26 in isolated pituitary cells from 14-day-old female rats. Calcium (Ca2+) responses were also used as a guide to determine whether the responsive cells belong to the lactosomatotroph lineage. Application of POMC1-76 or POMC1-26 induced a maintained oscillating [Ca2+]i increase in a small population of cells. Increasing doses of the peptides did not affect the magnitude and the frequency of [Ca2+]i oscillations but clearly augmented the number of responding cells. Approximately 2% of the cells responded at 0.1 nM POMC1-76 or 5 nM POMC1-26, and 11-13% of the cells responded at 10 nM and 500 nM of the respective peptides. About one-third of the cells responsive to these peptides also showed a [Ca2+]i increase in response to growth hormone-releasing peptide-6 (GHRP-6) while, in a small number of responsive cells, [Ca2+]i was depressed by dopamine, suggesting that the former cells are somatotrophs and the latter lactotrophs. This interpretation was confirmed by immunocytochemical identification of prolactin and growth hormone (GH) in the cells. Of the cells showing Ca2+ response to POMC1-76, approximately one-third contained GH and another third prolactin. The remainder contained neither GH nor prolactin. Comparable results were obtained with POMC1-26. The rise of [Ca2+]i induced by the N-terminal POMC peptides persisted after depletion of intracellular Ca2+ stores by thapsigargin. Removal of Ca2+ from the extracellular medium or addition of cadmium completely abolished both the POMC1-76- and POMC1-26-induced [Ca2+]i increase. Nifedipine inhibited the Ca2+ response to both peptides, although only in 55% of the responsive cells. Depletion of some isoforms of protein kinase C by preincubation with the phorbol ester PMA for 24 h did not modify the Ca2+ responses. In contrast, blockade of the protein kinase A pathway with Rp-cAMPs partially inhibited the POMC1-76- or POMC1-26-induced [Ca2+]i increase. The present data show that, in immature pituitary cells, POMC1-76 induces an increase in [Ca2+]i through extracellular Ca2+ influx, possibly mediated in part by protein kinase A activation. The active domain of POMC1-76 seems to comprise its N-terminal moiety. The data support the hypothesis that POMC1-76 exerts a specific function in the development of different members of the lactosomatotroph lineage and that the peptide mobilizes different subsets of cells within this lineage, by a mechanism determined by its concentration.
Study Information
pubmed
1998
1998-03-01T00:00:00.000Z
10.1046/j.1365-2826.1998.00192.x
5
62